BRD2 and Parkinson disease: However, NA loss in PD mouse models has been poorly evaluated in the literature, since in the conventional PD 6-OHDA-induced rat model, the NA transporter (NAT) is blocked prior to 6-OHDA infusion to prevent noradrenergic cell loss.